- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 196 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 141 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- October 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- November 2024
- 180 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2024
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- July 2023
- 118 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- January 2022
- 117 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- July 2024
- 132 Pages
Global
From €865EUR$950USD£741GBP
- Report
- July 2024
- 280 Pages
Global
From €2416EUR$2,655USD£2,071GBP
The Spine Biologics market is a subset of the larger Biotechnology industry. It focuses on the development of products and services that are used to treat spinal disorders and injuries. These products and services include tissue engineering, regenerative medicine, and stem cell therapies. They are used to repair, replace, or regenerate damaged or diseased spinal tissues. The goal of these treatments is to improve the quality of life for patients suffering from spinal disorders.
The Spine Biologics market is highly competitive, with many companies offering innovative products and services. Some of the major players in the market include Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, and NuVasive. These companies are constantly developing new technologies and treatments to improve the quality of life for patients with spinal disorders. Show Less Read more
